2023-505862-27-00CompletedPhase 1
A clinical trial to learn how an investigational drug (norucholic acid) is absorbed, distributed, broken down, and removed from the body when given to people with kidney problems
Dr. Falk Pharma GmbH, Dr. Falk Pharma GmbH1 site in 1 country48 target enrollmentStarted: October 6, 2023Last updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 48
- Locations
- 1
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (65+ Years, 18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
CTIS – Scientific Request
Scientific
Dr. Falk Pharma GmbH
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 1
A clinical trial to learn how an investigational drug (vimseltinib) is absorbed, distributed, broken down, and removed from the body when given to people with liver problems2023-503415-15-00Deciphera Pharmaceuticals Inc.32
Completed
Phase 1
This is clinical study to test, for the first time in people, the safety (any
good or bad effects), how long the drug can stay in the body and if it can
control the disease of people diagnosed with advanced cancer that has not
responded to treatment, has returned after it has been treated, or cannot
be treated by surgery, drugs, or any other known treatments.2023-509969-20-00Celgene Corp.127
Recruiting
Phase 1
clinical trial to determine the feasibility and safety of the mesenchymal stem cells use in women over 50 years of age with urinary incontinencee2024-514833-39-00Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz60
Completed
Phase 1
This is a clinical trial (study), to be conducted at multiple clinical sites, of an oral study drug (EP262) that will be investigated in adult participants with Chronic Inducible Urticaria (CIndU) to assess if it is safe and improves reactions to known CIndU triggers.2023-504800-28-00Escient Pharmaceuticals Inc.14
Not yet recruiting
Not Applicable
Evaluation of a Single-lead ECG Patch-based Telemetry System for In-hospital MonitoringVentricular TachycardiaAtrial FibrillationSupraventricular TachycardiaNCT07260721Yonsei University100